In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate' [3]

Nature Medicine

Volumn 13, Issue 1, 2007, Pages 14-

  Atallah, Ehab ^a   Kantarjian, Hagop ^a   Cortes, Jorge ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; DIURETIC AGENT; IMATINIB; INTERFERON;

CARDIOTOXICITY; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FLUID RETENTION; FOLLOW UP; HEART DISEASE; HEART EJECTION FRACTION; HUMAN; LETTER; MEDICAL RESEARCH; NONHUMAN; PRIORITY JOURNAL; THORAX RADIOGRAPHY;

ANTINEOPLASTIC AGENTS; HEART FAILURE, CONGESTIVE; HUMANS; LEUKEMIA, MYELOID, CHRONIC; NEOPLASMS; PIPERAZINES; PYRIMIDINES;

EID: 33846086176     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm0107-14     Document Type: Letter

References (3)

1. Kerkelä, R. et al. Nat. Med. 12, 908-916 (2006).
2. Kantarjian, H. et al. N. Engl. J. Med. 346, 645-652 (2002).
3. Kantarjian, H. et al. Clin. Cancer Res. 10, 68-75 (2004).